JAKAVI 20MG TABLET

Form: Tablets

Pack Size: 10 TABLETS

Marketed by: NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV)

MRP: ₹54600.00

NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV): Jakavi 20MG Tablet, 10 tablets, salt ruxolitinib 20mg. Its MRP stays at Rs 54,600 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 41,600. Group: JAK1/JAK2 inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: do not stop suddenly - symptoms can rebound. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.